ALGN Stock Analysis — Align Technology
Sector: Medical Devices
AI Verdict
ALGN trades at 14.2x next year's earnings with triple-digit growth expected, making it cheap for the growth you're getting if its digital orthodontics moat proves durable.
Competitive Moat
Align Technology owns the Invisalign brand and a proprietary digital orthodontics platform, giving it a defensible position through brand recognition and a large database of patient treatment data. Its digital workflow and patent portfolio create switching costs for orthodontists and clinics.
Summary
Align is notable right now for a forecasted 106.9% jump in earnings over the next year, far outpacing its recent 2.9% revenue growth.
Where It Stands
ALGN is down -10.06% over the past year, trades at 14.2x next year's earnings (well below the 22x sector median), and its RSI of 47.8 signals a cooling period.
Key Metrics
- RSI: 47.8 — Neutral
- Trailing P/E: 29.5x
- Forward P/E: 14.2x
- PEG Ratio: 0.26
- Earnings Growth: +1.1%
- Revenue Growth: +0.0%
- Market Cap: $12.6B
- 1-Year Return: -10.06%
- 52-Week High: $208.31
- 52-Week Low: $122.00
Analyst Consensus
17 Buy · 6 Hold · 1 Sell (24 analysts)
Bull Case
With forward EPS expected to more than double (+106.9%) and a forward P/E of just 14.2x, the stock is cheap for the growth on offer if Invisalign's moat holds.
Bear Case
If the forward P/E reverts to its trailing 29.5x multiple, the stock could see a sharp rerating, but if growth disappoints, even the current 14.2x could compress further, risking another double-digit decline.
Catalyst to Watch
Watch for quarterly earnings to confirm whether the 106.9% EPS growth materializes—any shortfall could trigger a valuation reset.